Target intelligence / Profile preview

Anaphase-promoting complex subunit CDC26 (CDC26)

Target
CDC26
Molecular classification
Enzyme (E3 ubiquitin ligase subunit), Multi-subunit protein complex subunit, Other (cell cycle regulatory complex member)
01

Overview

Anaphase-promoting complex subunit CDC26 (CDC26) is a protein that acts as an essential component of the Anaphase-promoting complex/cyclosome (APC/C), a large E3 ubiquitin ligase that controls cell cycle transitions by targeting key cell cycle regulators for ubiquitin-mediated proteolysis and subsequent degradation[3][4][5][7][10]. CDC26 itself has no apparent enzymatic activity, but instead is critical for the structural assembly and stabilization of the complex—especially its interaction with the TPR domain of APC6[1][6]. This function is conserved from yeast to humans, and loss of CDC26 disrupts APC/C activity leading to impaired cell division and growth defects. CDC26 is implicated in diseases associated with cell cycle dysfunction, notably cancer[5]. As of now, no clinically approved drugs are known to directly target CDC26 or the APC/C for therapeutic intervention, although the complex itself is a focal point for cell cycle inhibitor development, making CDC26 part of a therapeutically relevant molecular family.

Other names
CDC26ANAPC12APC12C9orf17Cell division cycle protein 26 homologanaphase-promoting complex subunit 12
02

Biological functions

Cell cycle regulationProteolysis (ubiquitin-mediated)Progression through mitosis and G1 phaseAssembly and structural stabilization of Anaphase-promoting complex (APC)
03

Disease associations

CancerCell proliferation disordersOther (Potential involvement in developmental pathways and regulation)

Beyond the preview

Go deeper on Anaphase-promoting complex subunit CDC26 (CDC26).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anaphase-promoting complex subunit CDC26 (CDC26).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call